This webinar includes a presentation on new and upcoming research and a discussion with experts and people with lived experience on what these advances mean. 
 

Summary  

Topics in the webinar included:

  • The benefits and limitations of psilocybin- and ketamine-assisted psychotherapy for methamphetamine use disorder. 

  • Ethical, clinical, and implementation considerations for these novel therapies 

  • The role of these therapies in existing treatment frameworks for methamphetamine use disorders.  

Panelists

Find out about our current research into methamphetamine treatment

Asset 2